The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: oxaliplatin     Quarter: 2016Q3

Total Records: 864     Number of Pages: 44

DRUGNAME PT EventCount
OXALIPLATIN. Joint stiffness 3
OXALIPLATIN. Metabolic acidosis 3
OXALIPLATIN. Metastases to lymph nodes 3
OXALIPLATIN. Metastasis 3
OXALIPLATIN. Muscle contractions involuntary 3
OXALIPLATIN. Myalgia 3
OXALIPLATIN. Myelofibrosis 3
OXALIPLATIN. Nephrogenic diabetes insipidus 3
OXALIPLATIN. Neutropenic sepsis 3
OXALIPLATIN. Palpitations 3
OXALIPLATIN. Pelvic abscess 3
OXALIPLATIN. Performance status decreased 3
OXALIPLATIN. Posterior reversible encephalopathy syndrome 3
OXALIPLATIN. Proctalgia 3
OXALIPLATIN. Prothrombin time prolonged 3
OXALIPLATIN. Purpura 3
OXALIPLATIN. Rectal adenocarcinoma 3
OXALIPLATIN. Renal failure 3
OXALIPLATIN. Respiratory depression 3
OXALIPLATIN. Splenomegaly 3

Total Records: 864     Number of Pages: 44